CIBC Private Wealth Group
INTS icon

CIBC Private Wealth Group’s Intensity Therapeutics INTS Stock Holding History

CIBC Private Wealth Group’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.06K Buy
201
+1
+0.5% +$10 ﹤0.01% 2794
2025
Q3 		$1.21K Hold
200
– – ﹤0.01% 2790
2025
Q2 		$1.53K Buy
+200
New +$4.11K ﹤0.01% 2700

Other funds holding INTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $1.07B AUM 26.49% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CIBC Private Wealth Group's INTS Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Intensity Therapeutics (INTS) stake by 0.5% in Q4 2025, buying an estimated $10 and bringing the position to 201 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

CIBC Private Wealth Group first reported a position in INTS in Q2 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold INTS as of Q4 2025.

  • CIBC Private Wealth Group held 201 shares of Intensity Therapeutics worth $2.06K as of Q4 2025.
  • CIBC Private Wealth Group bought 1 Intensity Therapeutics share in Q4 2025, an estimated $10.
  • Intensity Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2794 holding.
  • CIBC Private Wealth Group first reported a position in Intensity Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.